每日中译英，来自每日翻译

· 中译英

原文：

国产肺炎球菌13化合价结合疫苗是由云南沃森生物技术股份有限公司生产的。此前，只有纽约的辉瑞一家公司生产肺炎球菌结合疫苗。自2010年获准以来，该公司一直在不受挑战的市场中独领风骚。

该公司的13化合价肺炎球菌疫苗已在中国获准用于6周至5个月大的婴儿，超过6个月的婴儿不能接种疫苗；而获准的国产肺炎球菌13化合价结合疫苗却可用于更广的年龄范围：6周到5岁的儿童。

国产疫苗另有价格优势。在疫苗接种点，所有四种剂量的疫苗价格均接近3000元，沃森公司官员表示，新产品的价格不会超过辉瑞公司。

译文：

The domestic pneumococcal 13 valent conjugate vaccine was produced by Yunnan Watson Biotechnology Co., Ltd. Currently, only one Pfizer in New York produces pneumococcal conjugate vaccines. And since its approval in 2010, the company has been dominant in unchallenged markets.

The company's 13 composite pneumococcal vaccine has been approved in China for infants 6 weeks to 5 months. Infants over 6 months cannot be vaccinated. The approved domestic pneumococcal 13 conjugate vaccine is available for a wider age range of children from 6 weeks to 5 years.

Domestic vaccines also have a  price advantage. At the vaccination sites, the priceof the vaccine is nearly 3,000 yuanfor all four doses., and Watson officials said the new products will not cost more than Pfizer’s.